Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Eleanor T. McFadden"'
Publikováno v:
Controlled Clinical Trials. 16:30-65
Autor:
Eleanor T. McFadden
Publikováno v:
Controlled Clinical Trials. 12:674-675
Autor:
Martin M. Oken, Richard H. Creech, Paul P. Carbone, John Horton, Eleanor T. McFadden, Thomas E. Davis, Douglass C. Tormey
Publikováno v:
AMERICAN JOURNAL OF CLINICAL ONCOLOGY. 5:649-656
STANDARD CRITERIA FOR TOXICITY and for response to treatment are important prerequisites to the conduct of cancer trials. The Eastern Cooperative Oncology Group criteria for toxicity and response are presented to facilitate future reference and to en
Autor:
Leslie A. Kalish, Eleanor T. McFadden, Kishan J. Pandya, Samuel G. Taylor, Geoffrey Falkson, Douglass C. Tormey
Publikováno v:
Cancer. 55:202-205
A retrospective review of the Eastern Cooperative Oncology Group adjuvant chemotherapy studies EST 5177 and EST 6177 was performed in order to ascertain the first indicator of relapse in women with breast cancer and pathologically positive axillary l
Autor:
John H. Glick, Costan W. Berard, John M. Bennett, William Costello, Ediz Z. Ezdinli, Eleanor T. McFadden
Publikováno v:
Cancer. 49:840-845
Twenty-five patients with Stage III and IV nodular histiocytic lymphoma (NH), entered on three different Eastern Cooperative Oncology Group protocols from 1972-78, were analyzed for response and survival. A complete response (CR) rate of 44% was obse
Autor:
Leo L. Stolbach, Alan K. Hatfield, Harvey S. Brodovsky, Marvin Zelen, Burton Schwartz, Eleanor T. McFadden, Paul F. Engstrom, James N. Ingle, Colin B. Begg, Paul P. Carbone
Publikováno v:
Cancer. 52:1760-1767
The Eastern Cooperative Oncology Group, composed of major cancer treatment centers, has an outreach program which involves community hospitals in ongoing cancer clinical trials. A prevalence survey was carried out in February 1981 among 104 community
Autor:
Eleanor T. McFadden, Erica L. Orlow
Publikováno v:
Controlled Clinical Trials. 2:88
Autor:
Eleanor T. McFadden
Publikováno v:
Controlled Clinical Trials. 1:172